Peptris Technologies is an AI-driven preclinical drug discovery company specializing in oncology, inflammation, and rare diseases. By integrating unsupervised learning and generative AI, Peptris designs optimized molecules, significantly reducing the need for extensive wet lab testing. This approach streamlines the development of potent, safe, selective, and biologically active drug candidates. The company's platform has been instrumental in discovering Novel Chemical Entities (NCEs), repurposing approved drugs, and rescuing clinically safe molecules for new indications. Operating virtually, Peptris collaborates with Contract Research Organizations (CROs) and biotech partners for laboratory work, generating revenue through licensing deals, milestone payments, and royalties.
Key Features and Functionality:
- Novel Molecule Generation: Utilizes proprietary AI algorithms to create diverse, patentable, and synthesizable molecules with superior activity, selectivity, and optimal drug-like properties.
- Drug Repurposing: Identifies new therapeutic uses for approved drugs and clinically safe molecules, addressing unmet medical needs and rare disease indications.
- Automated Screening: Rapidly screens extensive virtual chemical libraries, predicting critical parameters with high accuracy to reduce the number of compounds requiring wet lab validation.
- Cost Efficiency: Minimizes the need for extensive laboratory testing, accelerating the drug discovery process and reducing associated costs.
Primary Value and Solutions Provided:
Peptris Technologies addresses the challenges of decreasing efficiency and escalating costs in pharmaceutical R&D by leveraging AI to enhance the drug discovery and development process. Their platform accelerates the identification of viable drug candidates, reduces reliance on traditional laboratory testing, and offers innovative solutions for repurposing existing drugs. This approach not only expedites the development of treatments for various diseases but also provides cost-effective and timely solutions for patients with unmet medical needs.
